This finding supports the notion that adverse effects of inhibition of IL-6 signaling (e.g., infection) are outweighed by the benefits of inhibiting this pathway (e.g., reduced risk of cardiovascular disease). The gene discussed is IL6; the disease is cardiovascular disorder.